The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trials: 'good to know' but not the whole story
J Hypertens
.
2019 Oct;37(10):1959-1960.
doi: 10.1097/HJH.0000000000002181.
Authors
Danijela Gasevic
1
,
Sophia Zoungas
Affiliation
1
Diabetes and Vascular Medicine Unit, The School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
PMID:
31464860
DOI:
10.1097/HJH.0000000000002181
No abstract available
Publication types
Editorial
Comment
MeSH terms
Blood Pressure
Cardiovascular Diseases*
Diabetes Mellitus*
Glucose
Humans
Hypoglycemic Agents
Incidence
Randomized Controlled Trials as Topic
Risk Factors
Substances
Hypoglycemic Agents
Glucose